1 / 17

Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection

Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection. Celeste Nadal. Purpose. Determine the epidemiological connections between cases of multidrug-resistant tuberculosis (MDRT) Prevention of future MDRT outbreaks. Rationale.

dee
Télécharger la présentation

Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection Celeste Nadal

  2. Purpose • Determine the epidemiological connections between cases of multidrug-resistant tuberculosis (MDRT) • Prevention of future MDRT outbreaks Rationale

  3. Outline • Background • Mycobacterium tuberculosis • Tuberculosis disease • HIV and Tuberculosis • Methods • Results • Conclusions

  4. Mycobacterium tuberculosis • Characteristics • Obligate aerobe • Rod shaped • Acid fast • Mycolic acid cell wall

  5. Tuberculosis Disease (TB) • Sites of infection • Mode of infection • Airborne

  6. Pulmonary TB • Internal symptoms • Development of tubercles • Consumption • Sputum • External symptoms • Minor cough • Mild fever • Fatigue • Weight loss • Coughing up blood • Chest pain

  7. TB and HIV • Increased susceptibility in immunosuppressed individuals • Infection in HIV positive individuals • 113 times more likely • 7 to 10% risk PER YEAR

  8. Multidrug-Resistant Tuberculosis Infection • Primary drug resistance • Infection with multidrug-resistant TB • Acquired drug resistance • Development of resistance during therapy • Possibly due to inadequate treatment

  9. Research Protocol • Trace M. tuberculosis transmission • Isolation and culture of bacterial sample • Evaluation of medical records • Follow-up studies • Radiometric broth method • Restriction-fragment-length polymorphisms analysis

  10. Radiometric Broth Method • Determine susceptibility to • Isoniazid (0.1-0.2 mg/ml) • Rifampin (2 mg/ml) • Streptomycin (6.0 mg/ml) • Ethambutol (7.5 mg/ml) • Pyrazinamide (100 mg/ml)- testing began later in study • Tests for critical concentration • The level of a drug which distinguishes the strain from a strain that has never been in contact with the drug • 1% colony growth in presence of antibiotic

  11. Restriction-Fragment-Length- Polymorphisms (RFLPs) Analysis • Form of DNA fingerprinting • Extract genomic DNA • Restriction enzyme digestion • PvuII • Southern blot • Gel electrophoresis • Transfer to nylon membrane • Hybridized with labeled probes

  12. RFLP Patterns of Patients with Persistently Drug-Susceptible Isolates

  13. RFLP Patterns of Patients with Increasingly Drug-Resistant Isolates

  14. RFLP Patterns Indicating Exogenous Reinfection with New Multidrug-Resistant Strain in HIV+ Patients

  15. Clinical Course of Four Patients with AIDS and Multidrug-Resistant Tuberculosis • Triangles • Out-patient visits • Circle • Negative TB culures • Boxes • Positive TB cultures • PCP • Pneumonia

  16. Conclusion • RFLP Analysis • Confirmed acquired drug resistance • Demonstrated Third mechanism of developing Multidrug-resistant tuberculosis infection • Exogenous reinfection • Follow-up • Lack of acquired immunity to MTB in HIV pos patients are more likely to become reinfected with MDR-TB

  17. Prevention • Routine skin testing for tuberculosis • Prompt and consistent treatment • Decrease open tuberculosis units

More Related